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Extra-cellular expansion in the normal, non-
infarcted myocardium is associated with
worsening of regional myocardial function
after acute myocardial infarction
Pankaj Garg1 , David A. Broadbent1,2, Peter P. Swoboda1, James R.J. Foley1, Graham J. Fent1, Tarique A. Musa1,
David P. Ripley1, Bara Erhayiem1, Laura E. Dobson1, Adam K. McDiarmid1, Philip Haaf1, Ananth Kidambi1,
Saul Crandon1, Pei G. Chew1, R. J. van der Geest3, John P. Greenwood1 and Sven Plein1*
Abstract
Background: Expansion of the myocardial extracellular volume (ECV) is a surrogate measure of focal/diffuse fibrosis
and is an independent marker of prognosis in chronic heart disease. Changes in ECV may also occur after
myocardial infarction, acutely because of oedema and in convalescence as part of ventricular remodelling. The
objective of this study was to investigate changes in the pattern of distribution of regional (normal, infarcted and
oedematous segments) and global left ventricular (LV) ECV using semi-automated methods early and late after
reperfused ST-elevation myocardial infarction (STEMI).
Methods: Fifty patients underwent cardiovascular magnetic resonance (CMR) imaging acutely (24 h–72 h) and at
convalescence (3 months). The CMR protocol included: cines, T2-weighted (T2 W) imaging, pre−/post-contrast T1-maps
and LGE-imaging. Using T2 W and LGE imaging on acute scans, 16-segments of the LV were categorised as normal,
oedema and infarct. 800 segments (16 per-patient) were analysed for changes in ECV and wall thickening (WT).
Results: From the acute studies, 325 (40.6%) segments were classified as normal, 246 (30.8%) segments as oedema and
229 (28.6%) segments as infarct. Segmental change in ECV between acute and follow-up studies (Δ ECV) was significantly
different for normal, oedema and infarct segments (0.8 ± 6.5%, −1.78 ± 9%, −2.9 ± 10.9%, respectively; P < 0.001). Normal
segments which demonstrated deterioration in wall thickening at follow-up showed significantly increased Δ ECV
compared with normal segments with preserved wall thickening at follow up (1.82 ± 6.05% versus −0.10 ± 6.88%, P < 0.05).
Conclusion: Following reperfused STEMI, normal myocardium demonstrates subtle expansion of the extracellular
volume at 3-month follow up. Segmental ECV expansion of normal myocardium is associated with worsening of
contractile function.
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Background
Following ST-elevation myocardial infarction (STEMI), even
with immediate mechanical reperfusion therapy, 24–30% pa-
tients develop adverse left ventricular (LV) remodelling [1,
2]. LV remodelling is a predictor of heart failure, and hence
is associated with morbidity and mortality. Post infarct, the
acute loss of myocardial function results in an abrupt in-
crease in LV loading conditions that induces a unique pat-
tern of remodelling involving the normal (non-infarcted
non-oedematous myocardium), oedematous (injured with
oedematous myocardium) and infarcted myocardium [3].
The chronic phase of LV remodelling involves com-
pensatory myocyte hypertrophy and alterations in ven-
tricular geometry to distribute the increased wall
stresses more evenly [4]. Early pre-clinical studies have
speculated that the ‘normal’ non-infarcted myocardium
also undergoes changes due to increased wall stress [5,
6]. There is limited evidence to support these concepts
in humans. Additionally, it remains unknown if these
changes in tissue composition of normal myocardium
have any impact on regional contractility.
Cardiovascular magnetic resonance (CMR) offers compre-
hensive multi-parametric structural and functional assess-
ment in patients with STEMI [7]. Using early gadolinium
enhancement (EGE) and late gadolinium enhancement
(LGE) imaging, accurate assessment of infarct characteristics
(infarct size, transmurality of scar, presence of microvascular
obstruction and LV thrombus) can be made. T2-weighted
(T2 W) imaging allows to diagnose and quantify the extent
of myocardial oedema following acute ischaemic injury [8,
9]. Native T1-mapping can also detect acute ischaemia and
combined with post contrast T1 mapping allows quan-
tification of the extra-cellular volume (ECV) [10–13].
This study aimed to investigate whether ECV expan-
sion of normal myocardium occurs after STEMI and
whether it is associated with a reduction in contractile
function between baseline and follow up assessment. We
also sought to determine the baseline CMR parameters
that are most strongly associated with segmental func-
tional change at follow up.
Methods
Study population
Patients with acute STEMI were prospectively enrolled
from a single UK tertiary centre. The study design is
detailed in Fig. 1.
The inclusion criteria were as follows: patients with
first time acute STEMI treated by primary percutaneous
Fig. 1 Study design
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coronary intervention (PPCI) within 12-h of onset of
chest pain. Acute STEMI was defined as per current
international guidelines [14]. Exclusion criteria included:
previous myocardial infaction, coronary artery bypass
grafting, known cardiomyopathy, estimated glomerular
filtration rate < 30 ml/min/1.73 m2, haemodynamic in-
stability (requiring on-going intravenous therapy or re-
spiratory support) and contraindication to CMR
imaging. After revascularization, all patients received
standard post-myocardial infarction secondary preven-
tion therapy at the discretion of the treating physician,
and were enrolled in a cardiac rehabilitation programme
if they were deemed suitable [15].
Cardiac catheterization
Coronary angiography and revascularisation were per-
formed in a standard fashion as per current best practice
guidelines [15, 16]. TIMI flow grades were assessed visually
as described previously following coronary angioplasty [17].
Cardiovascular magnetic resonance
All patients underwent CMR imaging at either 1.5 Tesla
(Ingenia CV, Philips Healthcare, Best, The Netherlands)
or 3.0 Tesla (Achieva TX, Philips Healthcare, Best, The
Netherlands). The choice of field strength was arbitrary
and was predominantly dictated by availability of the
scanners. A dedicated cardiac phased array receiver coil
was used (1.5 T: 24-channel equipped with d-stream;
3 T: 32-channel). Acute CMR imaging was scheduled
within 72-h of the index presentation and patients were
invited to attend for a further CMR study at 3-months
follow-up. The same field strength scanners were used
for respective patients as for the acute scans.
Image acquisition
Cine, T2 W-imaging, EGE and LGE imaging were per-
formed in contiguous stacks of short-axis slices covering
the entire LV for each acquisition. The same slice geom-
etry, position and 10 mm slice thickness were used for
all pulse sequences.
T1-maps acquisition
Native and post-contrast T1-maps were planned using
the ‘3-of-5’ approach [18]. Post-contrast T1-maps were
timed at 15 min after contrast administration and LGE-
imaging was performed at 16–20 min.
Image analysis
For each pulse sequence, images with artefact were re-
peated until any artefact was removed or minimized.
The highest quality images were used for analysis. Cine,
T2 W-images, EGE-images and LGE-images were evalu-
ated offline using MASS research software (Version
2016EXP, Leiden University Medical Centre, Leiden, The
Netherlands).
Basic CMR image analysis, T1-maps quality assurance
checks, pulse sequence parameters and imaging protocol
are described in the online Additional file 1.
Categorising of left ventricular segments
Sixteen segments of the LV excluding the apex, adapted
from the 17 segments of the American Heart Associ-
ation (AHA) model [19], were visually assessed on acute
CMR scans and labelled as 1) normal segment (no
oedema on T2 W-imaging and no infarct on LGE-
imaging), 2) oedema segment (predominantly oedema
on T2 W-imaging with no infarct on LGE-imaging 3) in-
farct segment (presence of any infarction on LGE-
imaging with/without oedema on T2 W-imaging).
Myocardial wall thickening analysis
Segmental myocardial systolic wall thickening (WT) ana-
lysis was performed for each slice based on endo- and epi-
cardial contours. For each segment, end-diastolic and end-
systolic wall thickness (EDWT and ESWT, respectively
[mm]) were recorded as per previously published literature
[20]. This method has demonstrated high intra-inter-
observer agreement [21]. Myocardial systolic segmental
WT ([mm]) was calculated as absolute change in EDWT
and ESWT. For each LV segment, delta change of WT was
derived. Functional improvement of segments was defined
as positive delta change of WT from baseline to follow-up
and vice versa. Additionally, radial strain was computed
using endo−/epi- cardial contours through-out the complete
cardiac cycle as per previously described methods [22].
Extracellular volume map analysis
ECV maps were generated for the 3 slices (base, mid
and apex) from pre−/post-contrast T1-maps and haem-
atocrit as per the standard techniques [10]. The endocar-
dial and epicardial contours were outlined to define
myocardium in the 3 slices. Microvascular obstruction
(MVO) contours were imported from EGE imaging.
Mean ECV values were generated for each segment of
the 16 segments excluding the MVO in the infarct zone.
Left ventricular global ECV was calculated by multiplica-
tion of the averaged per-patient ECV values (for all the
16 segments) and indexed LV end-diastolic volume
(LVEDV). Similarly, left ventricular myocyte cell volume
was calculated by using the previously published for-
mula: (1-global ECV)*(indexed LVEDV) [23]. For each
patient, mean ECV values for different types of segments
(normal, oedema and infarct) were generated on both
acute and follow-up studies. For each patient, increase
or decrease of ECV of all non-infarcted, healthy myocar-
dium was defined as the change in the mean ECV of all
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segments and this was investigated for its association
with patient characteristics (Table 1).
Adverse LV remodelling was defined as an absolute in-
crease of LV end-systolic volumes >15% at 3 months
follow-up [24, 25].
Intra−/inter-observer segmental ECV assessment
For intra−/inter-observer assessments, 48 segments were
selected from three randomly chosen scans. To test the
inter-observer reliability of segmental ECV values, two
blinded observers carried out independent segmentation
of ECV-maps (PG and SC) in these segments. To test
intra-observer reliability, one observer (PG) undertook a
second blinded analysis after three months.
Statistical analysis
Statistical analysis was performed using SPSS® Statistics
21.0 (International Business Machines, Inc., Chicago, Illi-
nois, USA). Normality of quantitative data was established
using the Shapiro-Wilk test. Normally distributed continu-
ous variables are expressed as mean ± SD and non-
normally distributed are expressed as median (25th–75th
quartile ranges). Demographic comparisons between pa-
tients with rise and fall of ECV at follow-up, in the normal
myocardial segments, were performed with an independent
samples t-test for normally distributed variables and by
Mann-Whitney independent t-test for not normally distrib-
uted. For paired comparison in Table 2, Wilcoxon test was
used. A repeated-measures analysis of variance (ANOVA)
was performed on demographic and global ECV (rise/fall)
at follow-up. Linear regression was used to investigate
which baseline study parameter was most strongly associ-
ated with number of segments with functional recovery at
follow-up. Univariate analysis was performed for each vari-
able separately. Step-wise multivariate linear regression was
used for parameters with statistical significance from one-
way analysis (p < 0.1). Intra−/inter-observer agreement was
assessed by investigating the coefficient of variability (CV),
concordance correlation coefficient (CCC), precision and
accuracy. All statistical tests were 2-tailed; p values <0.05
were considered significant.
Sample size calculations
We used data of remote zone ECV from published litera-
ture using to inform the sample size calculations for this
study. In a previous study, delta remote zone ECV in
patients with/without adverse LV remodelling were:
0.9 ± 2.2% (with adverse LV remodelling, n = 8) versus
0.9 ± 0.9% (without adverse LV remodelling, n = 32) [26].
Using these data, as per the mean comparison method de-
scribed by Machin et al., 295 normal segments were needed
to investigate functional changes. [27]. Presuming 40% of
myocardium is normal post STEMI, the study thus needed
to recruit at least 46 patients to give a power of 80% at an
alpha of 0.05.
Results
Patient characteristics
Seventy patients were considered for inclusion, of which
50 had baseline and follow-up CMR (Fig. 1). Acute scans
were performed at a median of 48 h after the index pres-
entation. 32 patients had CMR at 1.5 Tesla and 18 pa-
tients had CMR at 3 Tesla. All 50 patients were included
in the statistical analysis. Clinical and patient demo-
graphics are detailed in Table 1.
Per-patient analysis
Patients were categorised into two groups depending on the
rise/fall of normal myocardial ECV between baseline and
follow-up studies (Table 1). Twenty-eight patients (56%)
demonstrated an increase in average normal myocardial
ECV at follow-up when compared to acute ECV. No signifi-
cant differences were seen in baseline demographics between
the two groups of patients with a rise or fall of delta-ECV.
Patients with triple vessel disease were more prevalent in the
group that showed a rise in ECV in normal segments (1 pa-
tient versus 7 patients, P = 0.05). There were no differences
relating to the field strength of the scanner that was use and
the 3 T patients, 10 patients (55.6%) demonstrated ECV ex-
pansion in normal myocardial versus 18 (56.2%) on the
1.5 T (P = 0.96 for comparison of 3 T and 1.5 T). LV mass
reduced significantly from baseline to follow-up, but global
ECV and myocyte cell volume showed no significant change
(Table 2).
Per-segment analysis
800 segments were analysed acutely and at follow-up.
From the acute studies, 325 (40.6%) segments were clas-
sified as normal, 246 (30.8%) segments were classified as
oedema and 229 (28.6%) segments were classified as in-
farct segments. Myocardial oedema was only seen in the
peri-infarct zone of the culprit vessel.
Intra−/inter-observer checks for segmental ECV
For the 48 segments which were analysed, intra-observer
CV was 6%, with excellent CCC (0.94, 95% CI 0.90–97),
high precision (0.95) and accuracy (0.99). For the inter-
observer analysis, CV was 7%, with good CCC (0.92, 95%
CI 0.87–95) and high precision (0.93) and accuracy (0.99).
Pattern of ECV change
Oedema and infarct segments demonstrated significant
reductions in ECV at follow-up (Table 2). Conversely,
there was a smaller but statistically significant rise in the
ECV of normal myocardium at follow-up (P = 0.03).
Segmental change in ECV between acute and follow-
up studies was significantly different for normal, oedema
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Table 1 Clinical and angiographic characteristics in patients with change of normal segment ECV per-patient between acute and
follow-up scan
Normal segment
ECV ↓ (n = 22)
Normal segment
ECV ↑ (n = 28)
Mean/Median/Count SD/ 25%–75%/% Mean/Median/Count SD/25%–75%/% p-value
Patient Demographics
Age, yrs 60 11 58 11 0.39
Sex (Male)c 20 40 22 44 0.24
Smokerc 14 28 16 32 0.65
Hypertensionc 5 10 3 6 0.25
Hyperlipidaemiac 9 18 8 16 0.37
Diabetes Mellitusc 4 8 2 4 0.24
Strokec 1 2 0 0 0.26
Presenting Characteristics
Systolic Blood Pressure, mmHg 137 24 134 36 0.88
Heart rate, beats/min 73 14 74 16 0.95
Time from onset of CP to reperfusion, minc 261 158–454 222 149–344 0.43
Heart Failure Killip Classa
Ic 20 40 26 52 0.80
IIc 1 2 2 4 0.70
III-IVc 1 2 0 0 0.26
Ventricular fibrillation at presentationc 0 0 3 6 0.11
Angiographic Characteristics
Number of diseased arteriesb
Single vessel diseasec 16 30 16 32 0.26
Two vessel diseasec 5 10 5 10 0.67
Three vessel diseasec 1 2 7 14 0.05
Culprit Vessel
Left main stemc 0 0 1 2 0.37
Left anterior descendingc 14 28 15 30 0.48
Left circumflexc 2 4 2 4 0.80
Right coronaryc 6 12 11 22 0.38
QRS duration, msecc 90 86–110 94 82–100 0.86
TIMI coronary flow
pre-PCI (<2)c
18 36 26 52 0.15
TIMI coronary flow
post-PCI (<3)c
2 4 2 4 0.77
Laboratory results
White blood cellsc, ×109/l 11 10–15 11 10–13 0.86
Estimated Glomerular Filtration Ratec, ml/min/1.73m2 88 77–90 90 78–90 0.47
Creatine kinasec, U/l 1493 786–2400 1584 867–2570 0.75
Troponinc, 50,000 16,441–50,000 50,000 48,335–50,000 0.34
HBA1cc, mmol/mol 41 36–44 40 36–44 0.77
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and infarct segments (0.8 ± 6.5% versus −1.78 ± 9% or
−2.9 ± 10.9%; P < 0.001) (Fig. 2).
Temporal changes in normal segmental ECV did not
demonstrate any significant association with number of
>50% transmural scar segments (Fig. 3).
Segmental ECV and WT
Acute segmental ECV demonstrated significant correlation
to both acute segmental WT (P < 0.0001) and to follow-up
segmental WT (P < 0.0001) (Table 3). There was a signifi-
cant increase in ΔECV in normal segments which
Table 1 Clinical and angiographic characteristics in patients with change of normal segment ECV per-patient between acute and
follow-up scan (Continued)
Infarct characteristics
Infarct size, volume in % 30 17 26 12 0.42
Area at risk, volume in % 49 19 46 17 0.46
Presence of Microvascular Obstruction (MVO) 13 59 16 57 0.89
aKillip classification of heart failure after acute myocardial infarction: class I = no heart failure; class II = pulmonary rales or crepitations, a third heart sound, and
elevated jugular venous pressure; class III = acute pulmonary edema; and class IV = cardiogenic shock
bMulti-vessel coronary artery disease was defined according to the number of stenoses of at least 50% of the reference vessel diameter by visual assessment and
whether or not there was left main stem involvement
Abbreviations: BMI = body mass index; CMR = cardiac magnetic resonance; CP = chest pain; ECV = extracellular volume; HBA1c = glycated haemoglobin;
PCI = percutaneous coronary intervention; STEMI = ST-segment elevation myocardial infarction; TIMI = Thrombolysis In Myocardial Infarction
cNon-normally distributed
Table 2 Baseline and follow-up CMR parameters
Acute CMR Follow-up CMR P-valuea
Median 25%–75% quartiles Median 25%–75% quartiles
Baseline CMR characteristics
LVEDVi, ml/m2 79.1 71–87 80.45 70–89 0.41
LVESVi, ml/m2 42 36–50 38.7 31–47 0.02
LV MASSi, grams/m2 55.45 48–64 48.55 43–55 <0.0001
EF, % 45.65 36–51 52.35 43–59 <0.0001
IS, volume in % 23.9 17–38 13.75 9–27 <0.0001
Segmental myocardial tissue composition and function
Median 25% - 75% Quartiles Median 25% - 75% Quartiles
Normal ECV, %
(n = 325)
27.5 24.8–3 0.5 27.7 25.2–32 0.03
Oedema ECV, %
(n = 246)
34 29–39.3 32 28–37 0.0002
Infarct ECV, %
(n = 229)
44 37.4–49 41 33.6–46 <0.0001
Normal WT (mm)
(n = 325)
3.7 2.7–4.8 3.8 2.0–4.7 0.81
Oedema WT (mm)
(n = 246)
2.9 1.8–4.3 3.3 2.4–4.3 0.02
Infarct WT (mm)
(n = 229)
1.6 0.47–2.8 2.4 1.1–3.6 <0.0001
Normal EDT (mm) 7.3 6–8 6.7 6–7.5 <0.0001
Oedema EDT (mm) 7.4 6–8.5 6.5 5–7.6 <0.0001
Infarct EDT (mm) 7.9 7–9 6.4 56–7.6 <0.0001
Global myocardial tissue composition
Total LV myocyte volume, mL/m2 51.2 45.7–57.4 53.6 46.3–61 0.14
Total LV extracellular matrix, ml/m2 25.8 22.7–32.8 26.1 21.8–32.8 0.68
LV measurements are indexed to body surface area (BSA), infarct volumes are unindexed. LVEDVi = Left ventricular end-diastolic volume (indexed), LVESVi = Left
ventricular end-systolic volume (indexed), LVMi = Left ventricular mass (indexed), RS = peak systolic radial strain (%)
aWilcoxon test (paired samples)
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Fig. 2 Panel A and B: Scatter plot of 800 segmental ECV values and wall thickening acutely (a) and at follow-up (b). Panel C and D: Cluster bar
chart of delta ECV (c) and wall thickening (d)
Fig. 3 Cluster bar chart of delta ECV change in 800 segments divided into two categories: segments with functional deterioration and functional
improvement. Error bars represent standard deviation
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demonstrated deterioration in wall thickening (Table 3,
Fig. 4). For the oedema and infarct segments, ΔECV was
significantly different (less or no improvement) in segments
with a decrease in wall thickening versus segments that
demonstrated improvement in wall thickening (P < 0.05,
Table 3, Fig. 5). All segments with functional improvement
showed a reduction in follow-up ECV. The percentage
of “normal” myocardial segments that demonstrated
functional improvement and greater than normal
acute baseline ECV (>28%) was not significantly dif-
ferent to “normal” segments with no functional recov-
ery (54% versus 53%, P = 0.33).
Peak systolic radial strain results are detailed in the
online ‘Supplementary material’. Acute ECV of the
normal, oedema and infarct segments demonstrated
an inverse relation to final follow-up radial strain
(Fig. 6).
By univariable analysis of all demographic and CMR
parameters, acute oedema and infarct segment ECVs
demonstrated association to number of segments (per-
patient) that had improvement in function (Table 4). On
multivariable linear regression analysis, infarct ECV was
most strongly associated with number of segments with
functional improvement (beta = 0.4, P = 0.037).
Adverse LV remodelling
Acute myocardial ECV of normal segments was signifi-
cantly higher in patients who demonstrated adverse LV
remodelling (P = 0.04) (Table 5). Infarct and oedema
Table 3 Segmental function and extracellular volume (ECV) results
Left Ventricular Segmental Function (800 segments)
Acute WT Follow-up WT
Spearman rank correlation coefficient P-value Spearman rank correlation coefficient P-value
Acute ECV −0.46 <0.0001 −0.32 <0.0001
Follow-up ECV −0.34 <0.0001 −0.35 <0.0001
Function Deteriorated Function Improved
Mean SD n (%) Mean SD n (%)
Delta ECVa (%) Normal 1.82 6.05 158 (19.8) −0.10 6.88 167 (20.9) P < 0.05
Oedematous 0.12 8.72 107 (13.4) −3.25 9.05 139 (17.4) P < 0.05
Infarct −0.34 9.35 80 (10.0) −4.36 11.42 149 (18.6) P < 0.05
aTests are adjusted for all pairwise comparisons within a row of each innermost sub-table using the Bonferroni correction
Fig. 4 Frequency distribution histograms in normal, oedema and infarct segments with/without functional recovery from baseline to follow-up CMR
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acute ECV did not demonstrate a difference depending
on the presence of adverse LV remodelling at follow-up.
Discussion
The present study demonstrates that 1) in reperfused
STEMI, normal myocardial segments show a subtle ex-
pansion of the ECV between baseline and 3 month
follow-up; 2) conversely, oedematous and infarcted seg-
ments show a significant reduction in ECV at follow up;
3) normal segments that demonstrate deterioration in
segmental function at follow-up show a substantial in-
crease in delta-ECV from baseline to follow up; 4) acute
infarct ECV demonstrates the best association with the
number of segments with functional recovery (Fig. 3)
and 5) high acute normal myocardial segmental ECV is
associated with adverse LV remodelling at follow-up.
Previous studies have already shown that ECV is raised
in ‘remote’ myocardium in acute STEMI [26, 28]. Re-
mote myocardium is defined as the AHA segment 180-
degrees from the infarct territory with normal motion
Fig. 5 Box-and-whisker plot of temporal change in ECV of the normal myocardial segments and number of greater than 50 % transmural segments
per patient
Fig. 6 Scatter-plot of acute segmental ECV (x-axis) to follow-up peak systolic radial strain (y-axis)
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and no LGE [26, 28]. In the present study, we chose to
assess all segments that did not have evidence of oedema
or infarction and in order to avoid misinterpretation
with the standard definition of ‘remote’ myocardium,
defined these as ‘normal’ segments. Carberry et al.
demonstrated that acute remote zone ECV post STEMI
is associated with certain baseline patient characteristics
(male gender, body mass index and history of diabetes)
[28]. They also showed that the remote zone ECV was
associated with the level of baseline N-terminal pro b-
type natriuretic peptide (NT-proBNP). In our study the
number of patients with angiographic triple vessel dis-
ease was marginally higher in patients with increased
normal myocardial ECV when compared to patients
with 0−/1−/2-vessel disease (Table 1, P = 0.05). We
speculate that in triple vessel disease, coronary steal may
reduce flow in non-culprit vessels due to better flow
down the revascularised culprit vessel, which may cause
adverse tissue level remodelling [29–31]. Other possible
mechanisms which influence non-infarcted myocardium
include increased loading conditions secondary to infarct
characteristics. For example, Litwin et al.’s pre-clinical
work demonstrated that the extra-cellular matrix of the
non-infarcted normal myocardium undergoes expansion
mainly due to increased wall stresses [6].
Associations of segmental ECV and segmental and global
function have been studied previously [26, 32, 33]. Collins
et al. demonstrated that the segmental extent of fibrosis is
associated with segmental function in non-ischaemic car-
diomyopathy [33]. Additionally, they demonstrated that this
linear association was still relevant in patients with pre-
served global function and in patients with no late gadolin-
ium enhancement. Our study has now shown that mean
ECV is also associated with segmental function in patients
with acute STEMI. Bulluck et al. demonstrated that mean
segmental ECV in the remote myocardium is raised acutely
post STEMI (18). Their mean segmental remote myocardial
ECV values are comparable to the present study’s ‘normal’
myocardial segment ECV (27.9 ± 2.1%).
Remote (defined as normal myocardium in this study)
myocardial dysfunction after STEMI is considered the
main reason why some patients demonstrate function
loss that is disproportionate to infarct size [30, 34].
Bogaert et al. demonstrated that remote myocardial dys-
function contributes significantly to the loss in global
ventricular function. The present study confirms that
normal myocardium with no obvious oedema or infarc-
tion can also be affected by functional loss measured by
either LV wall thickening or radial strain. Additionally,
this study further shows that normal myocardial seg-
ments after acute MI which demonstrate dysfunction
also have significant extracellular matrix expansion. This
could be explained by increased reactive fibrosis during
the proliferative and maturation phase of remodelling, in
the extracellular matrix of the normal myocardial seg-
ments, mainly due to higher wall shear stresses [35].
A recent study from our group demonstrated that acute
‘infarct zone’ ECV is predictive of regional and global LV
functional recovery, and adds prognostic value over LGE
Table 4 Linear regression of baseline patient parameters to
number of myocardial segments with improved function at
follow-up study
Number of myocardial segments (per-patient) with improved function
Univariate Multivariate Beta
P-Value P-Value
Age 0.11
Sex 0.99
Diabetes Mellitus 0.57
Hypertension 0.69
Smoker 0.53
Time from onset of CP to reperfusion 0.93
Killip Class I 0.76
Killip Class II 0.85
Killip Class III-IV 0.79
Left main stem disease 0.14
1-vessel disease 0.48
2-vessel disease 0.67
3-vessel disease 0.87
TIMI flow pre-intervention 0.47
TIMI flow post intervention 0.47
LVEDV 0.74
LVESV 0.76
LV Mass 0.39
LV ejection fraction 0.51
Stroke volume 0.43
Infarct size 0.57
Area at risk (AAR) 0.18
Acute non-infarcted normal myocardial
ECV
0.89
Acute AAR ECV 0.05 0.32
Acute Infarct ECV 0.04 0.037 0.29
Table 5 Association of acute myocardial ECV to adverse LV
remodelling
LV AVR -ve LV AVR + ve P-value
Number of patients (n) 40 10
Acute non-oedematous,
non-infarcted healthy
myocardial ECV (%)
27.9 ± 3 30.4 ± 3.6 0.04
Acute infarct ECV (%) 43 ± 8 42 ± 6 0.61
Acute oedema ECV (%) 35.1 ± 6 33.3 ± 4 0.41
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[36]. Particularly for infarcts with higher transmural extent,
acute infarct ECV was an additional predictor of functional
recovery that can complement transmural infarct extent by
LGE. In addition to these previously reported findings, we
have now shown that acute infarct mean segmental ECV
correlates with segmental functional recovery at follow-up
and that a reduction in ECV in infarct segments is associ-
ated with improvement in regional function at follow-up.
This is the first in-vivo study that reports longitudinal
changes in segmental ECV in non-infarcted normal,
oedema and infarcted LV segments. Our data suggest that
non-oedematous, non-infarcted normal LV myocardium
undergoes remodelling with a subtle expansion of the
extracellular matrix (Fig. 7). In particular, normal myocar-
dial segments which demonstrate myocardial functional
loss at follow-up have an increase in ECV.
Limitations
Of 70 patients that underwent initial screening for re-
cruitment only 50 patients underwent the entire proto-
col possibly introducing an element of selection bias.
However, in a clinical study of acutely ill patients, exclu-
sion or drop out of patients is common and our exclu-
sion rate is within that reported in similar previous
reports [9, 37]. There were other caveats to the present
study: firstly, segments specifically classified as infarct
also conceivably had oedema, which may have altered
the results for respective segments. An important limita-
tion of T1-mapping for clinical application is possible
partial volume contamination from blood. Nevertheless,
MOLLI sequences used in the present study, have been
shown to be precise and reproducible [38]. The results
of this study may be influenced by the tethering and
local interaction of “adjacent” (to peri-infarct zone) nor-
mal myocardium. Changes in the adjacent normal myo-
cardium may demonstrate a different pattern of temporal
changes when compared to remote myocardium.
Conclusion
This study suggests that following reperfused STEMI,
the ‘normal’ LV myocardium undergoes remodelling
with a subtle expansion of the extracellular matrix. In
particular, normal segments which have functional loss
demonstrate significant expansion of the extracellular
space. Additionally, acute myocardial ECV of normal
segments was significantly higher in patients who experi-
enced adverse LV remodelling. Myocardial segments
with oedema and infarction demonstrate significant re-
duction in ECV.
Fig. 7 Illustration to demonstrate changes in tissue composition post-acute reperfused myocardial infarction. The infarcted myocardial segments
demonstrate reduction in overall ECV on follow-up as the damaged myocytes recover function even in the presence of scar. This leads to some
function improvement in these infarcted segments. The oedema segments demonstrate significant reduction in ECV as the water content of
extracellular matrix falls. Oedema segments also demonstrate significant improvement in function. The normal segments undergo physiological
adaptation with involves increase in extracellular volume. This is likely to be the result of overall left ventricular remodelling
Garg et al. Journal of Cardiovascular Magnetic Resonance  (2017) 19:73 Page 11 of 13
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